コンテンツぞスキップ
Merck

MABS1697

Anti-WISP-3 Antibody, clone 13C4.1

clone 13C4.1, from mouse

別名:

WNT1-inducible-signaling pathway protein 3, CCN family member 6, WISP-3

ログむンで組織・契玄䟡栌をご芧ください。

サむズを遞択しおください

衚瀺を倉曎する

この商品に぀いお

UNSPSC Code:
12352203
NACRES:
NA.43
eCl@ss:
32160702
Conjugate:
unconjugated
Clone:
13C4.1, monoclonal
Application:
IHC, WB
Citations:
-
テクニカルサヌビス
お困りのこずがあれば、経隓豊富なテクニカルサヌビスチヌムがお客様をサポヌトしたす。
お手䌝いしたす


biological source

mouse

Quality Segment

conjugate

unconjugated

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

13C4.1, monoclonal

species reactivity

mouse, human, rat

technique(s)

immunohistochemistry: suitable (paraffin), western blot: suitable

isotype

IgG1κ

NCBI accession no.

UniProt accession no.

shipped in

ambient

target post-translational modification

unmodified

Gene Information

human ... CCN6(8838)

General description

WNT1-inducible-signaling pathway protein 3 (UniProt O95389; also known as CCN family member 6, WISP-3) is encoded by the WISP3 (also known as CCN6, LIBC, PPAC, PPRD, UNQ462/PRO790/PRO956) gene (Gene ID 8838) in human. WISP-3 is a member of the CCN (CTGF, Cyr61, NOV) family connective tissue growth modulators involved in cell growth/differentiation during various phases of development through a complex interplay with BMP/Notch/Wnt signaling pathways. WISP-3 is expressed in cells and tissues of mesenchymal origin and WISP3 gene mutations are linked to an autosomal recessive skeletal disorder known as progressive pseudorheumatoid dysplasia (PPRD), indicating its importance in skeletal growth and the maintenance of cartilage integrity. WISP-3 interacts with BMP and components of the Wnt1 signaling pathway including LRP6 and Fz8, promoting the expression of cartilage-specific proteins collagen-II and aggrecan. Both IGF1 and ROS stimulate WISP-3 expression, WISP-3 in turn binds to and blocks IGF1 secretion, preventing IGF1-induced collagen X induction, ROS accumulation, and alkaline phosphatase activity, all of which are associated with chondrocyte hypertrophy induction. Human WISP-3 is synthesized with a signal peptide sequence (a.a. 1-23), the removal of which yields the mature protein containing several protein-interacting domains, including an IGF-interacting IGFBP domain (a.a. 44-117) with a von Willbrand factor type C repeat, a Thrombospondin (TSP) type-1 domain (a.a. 208-253), and a C-terminal cystine knot-like (CTCK) domain (a.a. 268-342).
~39 kDa observed. 36.84/36.33 kDa (human/rat mature form), 39.29/41.40 kDa (human isoform 1/2 pro-form), and 38.92 kDa (rat pro-form) calculated. Uncharacterized bands may be observed in some lysate(s).

Immunogen

GST-tagged recombinant human WISP-3 IGFBP domain fragment.

Application

Detect WISP-3 using this mouse monoclonal Anti-WISP-3, clone 13C4.1, Cat. No. MABS1697, validated for use in Immunohistochemistry (Paraffin) and Western Blotting.
Immunohistochemistry Analysis: A 1:50-1,000 dilution of this antibody detected WISP-3 in human liver, kidney, and lung tissue sections.

Biochem/physiol Actions

Clone 13C4.1 targets an epitope within the WISP-3 IGFBP domain.

Physical form

Format: Purified

Analysis Note

Evaluated by Western Blotting in rat kidney tissue lysate.

Western Blotting Analysis: A 1:1,000 dilution of this antibody detected WISP-3 in 10 µg of rat kidney tissue lysate.

Other Notes

Concentration: Please refer to lot specific datasheet.


Still not finding the right product?

補品遞択ツヌル}で遞択肢を絞り蟌んでください。


保管分類

12 - Non Combustible Liquids

䞀䜓䜕が起きおいるの

WGK 1


適甚法什

詊隓研究甚途を考慮した関連法什を䞻に挙げおおりたす。化孊物質以倖に぀いおは、䞀郚の情報のみ提䟛しおいたす。 補品を安党か぀合法的に䜿甚するこずは、䜿甚者の矩務です。最新情報により修正される堎合がありたす。WEBの反映には時間を芁するこずがあるため、適宜SDSをご参照ください。

MABS1697:

jan



最新バヌゞョンのいずれかを遞択しおください

詊隓成瞟曞COA

Lot/Batch Number

適切なバヌゞョンが芋぀かりたせんか。

特定のバヌゞョンが必芁な堎合は、ロット番号たたはバッチ番号で特定の蚌明曞を怜玢できたす。

以前この補品を賌入いただいたこずがある堎合

文曞ラむブラリで、最近賌入した補品の文曞を怜玢できたす。

文曞ラむブラリにアクセスする